Cargando…

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress

BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellings, Peter W., Muraro, Antonella, Fokkens, Wytske, Mullol, Joaquim, Bachert, Claus, Canonica, G. Walter, Price, David, Papadopoulos, Nikos, Scadding, Glenis, Rasp, Gerd, Demoly, Pascal, Murray, Ruth, Bousquet, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621924/
https://www.ncbi.nlm.nih.gov/pubmed/26509001
http://dx.doi.org/10.1186/s13601-015-0080-9
_version_ 1782397521260183552
author Hellings, Peter W.
Muraro, Antonella
Fokkens, Wytske
Mullol, Joaquim
Bachert, Claus
Canonica, G. Walter
Price, David
Papadopoulos, Nikos
Scadding, Glenis
Rasp, Gerd
Demoly, Pascal
Murray, Ruth
Bousquet, Jean
author_facet Hellings, Peter W.
Muraro, Antonella
Fokkens, Wytske
Mullol, Joaquim
Bachert, Claus
Canonica, G. Walter
Price, David
Papadopoulos, Nikos
Scadding, Glenis
Rasp, Gerd
Demoly, Pascal
Murray, Ruth
Bousquet, Jean
author_sort Hellings, Peter W.
collection PubMed
description BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom control is unknown, as is the level of AR control perceived by physicians who treat patients. METHODS: 307 voluntarily selected physicians attending the annual (2013) European Academy of Allergy and Clinical Immunology (EAACI) meeting completed a digital survey. Delegates were asked to (1) estimate how many AR patients/week they saw during the season, (2) estimate the proportion of patients they considered to have well-, partly- and un-controlled AR, (3) communicate how they gauged this control and (4) assess how useful they would find a VAS as a method of gauging control. 257 questionnaires were filled out completely and analysed. RESULTS: EAACI delegates reported seeing 46.8 [standard deviation (SD) 68.5] AR patients/week during the season. They estimated that 38.7 % (SD 24.0), 34.2 % (SD 20.2) and 20.0 % (SD 16.34) of their AR patients had well-controlled (no AR symptoms), partly-controlled (some AR symptoms), or un-controlled-(moderate/severe AR symptoms) disease despite taking medication [remainder unknown (7.1 %)]. However, AR control was assessed in many ways, including symptom severity (74 %), frequency of day- and night-time symptoms (67 %), activity impairment (57 %), respiratory function monitoring (nasal and/or lung function; 40 %) and incidence of AR exacerbations (50 %). 91 % of delegates felt a simple VAS would be a useful tool to gauge AR symptom control. CONCLUSIONS: A substantial portion of patients with AR are perceived as having uncontrolled or partly controlled disease even when treated. A simple VAS score is considered a useful tool to monitor AR control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-015-0080-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4621924
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46219242015-10-28 A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress Hellings, Peter W. Muraro, Antonella Fokkens, Wytske Mullol, Joaquim Bachert, Claus Canonica, G. Walter Price, David Papadopoulos, Nikos Scadding, Glenis Rasp, Gerd Demoly, Pascal Murray, Ruth Bousquet, Jean Clin Transl Allergy Research BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom control is unknown, as is the level of AR control perceived by physicians who treat patients. METHODS: 307 voluntarily selected physicians attending the annual (2013) European Academy of Allergy and Clinical Immunology (EAACI) meeting completed a digital survey. Delegates were asked to (1) estimate how many AR patients/week they saw during the season, (2) estimate the proportion of patients they considered to have well-, partly- and un-controlled AR, (3) communicate how they gauged this control and (4) assess how useful they would find a VAS as a method of gauging control. 257 questionnaires were filled out completely and analysed. RESULTS: EAACI delegates reported seeing 46.8 [standard deviation (SD) 68.5] AR patients/week during the season. They estimated that 38.7 % (SD 24.0), 34.2 % (SD 20.2) and 20.0 % (SD 16.34) of their AR patients had well-controlled (no AR symptoms), partly-controlled (some AR symptoms), or un-controlled-(moderate/severe AR symptoms) disease despite taking medication [remainder unknown (7.1 %)]. However, AR control was assessed in many ways, including symptom severity (74 %), frequency of day- and night-time symptoms (67 %), activity impairment (57 %), respiratory function monitoring (nasal and/or lung function; 40 %) and incidence of AR exacerbations (50 %). 91 % of delegates felt a simple VAS would be a useful tool to gauge AR symptom control. CONCLUSIONS: A substantial portion of patients with AR are perceived as having uncontrolled or partly controlled disease even when treated. A simple VAS score is considered a useful tool to monitor AR control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-015-0080-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-27 /pmc/articles/PMC4621924/ /pubmed/26509001 http://dx.doi.org/10.1186/s13601-015-0080-9 Text en © Hellings et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hellings, Peter W.
Muraro, Antonella
Fokkens, Wytske
Mullol, Joaquim
Bachert, Claus
Canonica, G. Walter
Price, David
Papadopoulos, Nikos
Scadding, Glenis
Rasp, Gerd
Demoly, Pascal
Murray, Ruth
Bousquet, Jean
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
title A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
title_full A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
title_fullStr A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
title_full_unstemmed A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
title_short A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
title_sort common language to assess allergic rhinitis control: results from a survey conducted during eaaci 2013 congress
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621924/
https://www.ncbi.nlm.nih.gov/pubmed/26509001
http://dx.doi.org/10.1186/s13601-015-0080-9
work_keys_str_mv AT hellingspeterw acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT muraroantonella acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT fokkenswytske acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT mulloljoaquim acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT bachertclaus acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT canonicagwalter acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT pricedavid acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT papadopoulosnikos acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT scaddingglenis acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT raspgerd acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT demolypascal acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT murrayruth acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT bousquetjean acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT hellingspeterw commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT muraroantonella commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT fokkenswytske commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT mulloljoaquim commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT bachertclaus commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT canonicagwalter commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT pricedavid commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT papadopoulosnikos commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT scaddingglenis commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT raspgerd commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT demolypascal commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT murrayruth commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress
AT bousquetjean commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress